Severity
Low
FDA Drug recall · Reported November 11, 2020
Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.
Aurobindo Pharma USA Inc. recalled Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Relieve… - a low-severity action.
Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Relieve… was recalled by Aurobindo Pharma USA Inc. in November 11, 2020. Reason: Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.. Check the official notice for the remedy. Verify recall #D-0065-2021 with the FDA Drug before acting.
The recall
Aurobindo Pharma USA Inc. issued this low-severity FDA Drug recall-Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups..
Sourced from official FDA Drug enforcement records. Verify recall #D-0065-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0065-2021) was formally reported on November 11, 2020, with the manufacturer initiating the action on October 22, 2020. It is classified under Low severity (Class III), with a current status of Terminated. Aurobindo Pharma USA Inc. is listed as the recalling firm, operating out of East Windsor, NJ. Federal records list the affected scope as 7440 bottles.
The documented reason for this recall is: Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups. Distribution data in the federal record shows the product reached: NJ. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
7440 bottles
Related Recalls
6
5 from same agency
Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever Reducer, 4 fl oz (120 mL), Berry Flavor, Distributed by Chalkboard Health Inc. Princeton, NJ 08540 getfluenthealth.com Made in India. NDC 79395-003-92
Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0065-2021 |
| Date reported | November 11, 2020 |
| Date initiated | October 22, 2020 |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Firm location | East Windsor, NJ |
| Affected scope | 7440 bottles |
| Distribution | NJ |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported November 11, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.